Animal studies also showed that chronic administration of recombinant CT-1 improved hepatic steatosis in high-fat diet-induced NAFLD mice through inhibition of lipogenesis and enhancement of fatty acid breakdown [25]. The gene discussed is CTF1; the disease is metabolic dysfunction-associated steatotic liver disease.